Miga Health is a heart health platform focused on preventing the next million heart attacks and strokes.https://www.migahealth.com/
Miga Health is an end-to-end vertical treatment platform for hypertension (high blood pressure) centered around the consumer. Miga was founded by Dr. Jarrad Aquirre (Yale undergrad, Rhodes Scholar, Stanford MD / MBA) and Dre Limberopoulos (previous founder of a wearable tech company and an early employee at TrialSpark) in Q4 2021.
Miga Health is a digital-first provider of hypertension-related care. Consumers sign up for a monthly subscription to Miga, and will be able to purchase add-ons (e.g., medication and quarterly lab check-ins). In return, Miga will send the consumer a free cuff for measuring blood pressure and plans to offer additional services, including a virtual community, personalized coaching, gamified collection of blood pressure (BP) readings, data shared with a PCP or physician, medication management, and fingerstick labs.
Almost half of all adults in the U.S. (>116 million) have some form of hypertension. Approximately 37 million adults have stage 2 hypertension, defined as blood pressure of 140/90 mmHg or higher, and are usually recommended to take medication along with lifestyle changes. It is estimated that approximately $130-$200 billion is spent on hypertension annually in the U.S. Expanding to include the larger cardiovascular market, it is estimated that cardiovascular issues cost the U.S. ~$360 billion annually.
Yale (BS, Biology), University of Oxford (MPhil, Medical Anthropology), Stanford University School of Medicine (MD), Stanford University Graduate School of Business (MBA)
Monash University (BSE, Bachelor of Software Engineering)
Cardiovascular disease is one of the largest and most expensive diseases in the U.S., causing 1 in 3 deaths and costing society upwards of $360 billion annually. However, ~80% of premature heart attacks and strokes are preventable. Hypertension is the foremost modifiable risk for cardiovascular disease and is highly prevalent. The current solution for treating hypertension is fragmented, inconvenient, and leaves the onus on the patient, who must actively show up in person, be diligent about recording their blood pressure daily with no short-term incentives, coordinate sporadic check-ins with their doctor, visit labs for blood tests, etc. We see Miga Health in the broader context of our theme around patient-centric disruptive solutions for chronic disease.